2004

  1. Budesonide or prednisolone in pediatric CD

  2. Infliximab +/- ciprofloxacin in perianal CD

  3. 5ASA vs AZA in CD for postoperative recurrence

  4. 5ASA vs 6MP in CD for postoperative recurrence

  5. Oral aloe vera in active UC

  6. Infliximab in fistulising CD

  7. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis

  8. Genetic variation in DLG5 is associated with inflammatory bowel disease

  9. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease

  10. High prevalence of adherent-invasive *Escherichia coli* associated with ileal mucosa in Crohn’s disease